The transcriptome of CD14 CD163 HLA-DR monocytes predicts mortality in Idiopathic Pulmonary Fibrosis

Theodoros Karampitsakos,Bochra Tourki,Minxue Jia,Carole Y Perrot,Bogdan Visinescu,Amy Zhao,Avraham Unterman,Argyris Tzouvelekis,Debabrata Bandyopadhyay,Brenda M Juan-Guardela,Antje Prasse,Imre Noth,Stephen Liggett,Naftali Kaminski,Panayiotis V Benos,Jose D Herazo-Maya

DOI: https://doi.org/10.1101/2024.08.07.24311386

2024-09-11

Abstract:Rationale: The association between immune-cell-specific transcriptomic profiles and Idiopathic Pulmonary Fibrosis (IPF) mortality is unknown. Objectives: To determine immune-cell-specific transcriptomic profiles associated with IPF mortality. Methods: We profiled peripheral blood mononuclear cells (PBMC) in 18 participants [University of South Florida: IPF, COVID-19, post-COVID-19 Interstitial Lung Disease (Post-COVID-19 ILD), controls] by single-cell RNA sequencing (scRNA-seq) and identified 16 immune-cell-specific transcriptomic profiles. The Scoring Algorithm of Molecular Subphenotypes (SAMS) was used to calculate Up-scores based on these 16 gene profiles. Their association with outcomes was investigated in peripheral blood, Bronchoalveolar Lavage (BAL) and lung tissue of N=416 IPF patients from six cohorts. Findings were validated in an independent IPF, PBMC scRNA-seq dataset (N=38). Measurements and main results: Cox-regression models demonstrated that 230 genes from CD14 CD163 HLA-DR circulating monocytes predicted IPF mortality [Pittsburgh (p=0.02), Chicago (p=0.003)]. PBMC proportions of CD14 CD163 HLA-DR monocytes were higher in progressive versus stable IPF (Yale, 0.13±0.05 versus 0.09±0.05, p=0.034). Receiving operating characteristic identified a 230 gene, Up-score >41.84 (Pittsburgh) predictive of mortality in Chicago (HR: 6.58, 95%CI: 2.15-20.13, p=0.001) and in pooled analysis of BAL cohorts (HR: 2.20, 95%CI: 1.44-3.37, p=0.0003). High-risk patients had decreased expression of the T-cell co-stimulatory genes , , and (Pittsburgh and Chicago, p<0.01). 230 gene-up-scores negatively correlated with Forced Vital Capacity (FVC) in IPF lung tissues (LGRC, rho=-0.2, p=0.02). Results were replicated using a subset of 13 genes from the 230-gene signature (pooled PBMC cohorts - HR: 5.34, 95%CI: 2.83-10.06, p<0.0001). Conclusions: The transcriptome of CD14 CD163 HLA-DR monocytes is associated with increased IPF mortality.

Respiratory Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to determine whether the transcriptome characteristics of specific immune cell subsets are related to the mortality of patients with idiopathic pulmonary fibrosis (IPF). Specifically, the researchers hope to identify immune cell subsets that can predict the death risk of IPF patients and their gene expression characteristics by analyzing single - cell RNA sequencing data in peripheral blood mononuclear cells (PBMCs).

### Research Background
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and unpredictable lung disease. Although previous studies have found some gene markers related to IPF mortality, these markers are mainly concentrated in the overall blood samples and fail to clarify the relationship between the transcriptome characteristics of specific immune cell subsets and IPF mortality.

### Research Objectives
The main objectives of this study are:
1. **Determine the transcriptome characteristics of immune cell subsets**: Identify specific immune cell subsets related to IPF mortality and their gene expression characteristics through single - cell RNA sequencing technology.
2. **Verify the predictive ability of these characteristics**: Verify whether these gene expression characteristics can accurately predict the death risk of IPF patients in multiple independent cohorts.

### Methods
The researchers used single - cell RNA sequencing (scRNA - seq) technology to analyze peripheral blood mononuclear cells (PBMCs) from different cohorts, including:
- The University of South Florida cohort
- The Yale University cohort
- The Pittsburgh cohort
- The Chicago cohort
- Other cohorts (such as BAL and lung tissue)

By analyzing these data, the researchers identified 16 different immune cell subsets and generated corresponding gene expression profiles. Then, they used Cox regression models and receiver operating characteristic curve (ROC) analysis to evaluate the performance of these gene expression profiles in predicting the mortality of IPF patients.

### Main Findings
1. **Transcriptome characteristics of CD14+CD163 - HLA - DRlow monocytes**: The study found that the transcriptome characteristics of CD14+CD163 - HLA - DRlow monocytes are significantly related to the mortality of IPF patients. Specifically, the expression levels of these 230 genes can predict the survival of patients.
2. **Reduced gene expression in T - cell co - stimulatory signaling pathways in high - risk patients**: In high - risk patients, the expression levels of T - cell co - stimulatory signaling pathway genes (such as CD28, ICOS, ITK and LCK) are significantly reduced, indicating that these patients may have an immunosuppressive effect.
3. **Risk characteristics of 13 genes**: Thirteen key genes were screened from 230 genes, and these genes can also accurately predict the death risk of IPF patients in multiple cohorts.

### Conclusions
This study reveals a significant association between the transcriptome characteristics of CD14+CD163 - HLA - DRlow monocytes and the mortality of IPF patients. This finding not only helps to understand the pathogenesis of IPF, but also provides potential therapeutic targets for future precision medicine.